Eficacia de los probióticos en el control del Helicobacter Pylori

Abstract

Introduction: Helicobacter pylori, a gram-negative micro aerobic bacterium that is not part of the intestinal microbiome, impacts the majority of the population with an incidence of 4.4 billion worldwide, was included in 2017 as antibiotic resistant bacteria, for such reason it seeks to implement the use of probiotics which confers benefits in the health of the host. Obj: To identify the effectiveness of probiotics in the control of Helicobacter pylori, by searching for scientific studies of the last 5 years, for the updating of health personnel. Methods: Retrospective and observational descriptive study concerning the efficacy of probiotics in the control of H. Pylori. For the collection of information, reliable databases such as PubMed, LILACS and Scielo were used, by searching MeSh and DeSC descriptors together with Boolean operators; the following equation was used: Helicobacter pylori and probiotics or antibiotics and eradication. Conclusions: Probiotics improve the eradication rate and decrease adverse effects when used in conjunction with antibiotic treatment. Saccharomices boulardii, (S. boulardii) and Lactobacillus reuteri (L.reuteri) are the probiotic strains of choice that show the best results in the eradication rate with 94.2% and 92% respectively. For antibiotic therapy to generate gastrointestinal improvement, increase the eradication rate and alleviate clinical symptoms, it should be implemented for 14 days.